The U.S. Senate passed the Opioid Crisis Response Act on Monday, Sept. 17. The bill will authorize $7.9 billion for health agencies, including the CDC and HHS. It includes a provision that may facilitate the development on ultrasound-based therapies, a move supported by the Medical Imaging & Technology Alliance (MITA).